Find here all our blog posts tagged with: GDPR.

Overlapping translucent glass panels symbolizing layered European regulatory frameworks converging over pharmaceutical research.

The Non-Device Trap in EU Pharma AI

US pharma AI tools that avoid MDR device classification still face full exposure under the EU AI Act, GDPR, and EHDS.

Abstract visualization of data nodes split between localized and centralized routing paths across a translucent regional boundary.

The Architecture Decision Pharmacovigilance AI Cannot Defer

Cross-jurisdictional data rules are forcing pharma safety teams to choose between centralized and localized AI architectures before regulators force the choice for them.

A human silhouette made of light particles dissolving between physical form and abstract data streams in a clinical setting.

Simulation-Guided Trials Are Ahead of the Law

Digital twins and virtual control arms are entering pivotal trial design faster than GDPR and MDR frameworks can validate the data behind them.